field
viru
discoveri
burgeon
advent
high
throughput
sequenc
platform
bioinformat
program
enabl
rapid
identif
molecular
character
known
novel
agent
invest
global
microbi
surveil
includ
wildlif
domest
anim
well
human
recognit
virus
may
implic
chronic
well
acut
diseas
review
method
viral
surveil
discoveri
strategi
pitfal
link
discoveri
diseas
identifi
opportun
improv
sequenc
instrument
analysi
use
social
media
medic
informat
advanc
clinic
medicin
public
health
chang
dynam
emerg
virus
result
increasingli
import
role
viral
discoveri
diagnost
clinic
medicin
public
health
global
travel
trade
domest
anim
anim
product
bush
meat
traffick
polit
instabl
bioterror
well
climat
chang
effect
vector
distribut
facilit
emerg
reemerg
zoonos
virus
previous
restrict
one
host
speci
geograph
region
appear
unexpect
locat
confound
clinician
unprepar
recogn
new
syndrom
detect
new
pathogen
exist
diagnost
test
immunosuppress
associ
organ
transplant
chemotherapi
hivaid
enabl
virus
limit
virul
becom
pathogen
increas
appreci
potenti
role
virus
chronic
cardiovascular
endocrin
neurodevelopment
neoplast
disord
coupl
grow
repertoir
diagnost
tool
techniqu
result
reenerg
quest
associ
pathogen
figur
burgeon
interest
discoveri
diagnost
also
practic
applic
given
recent
improv
drug
vaccin
lack
effect
therapi
made
diagnosi
viral
infect
primarili
academ
exercis
howev
expand
armamentarium
countermeasur
specif
virus
promis
unpreced
opportun
reduc
morbid
mortal
econom
cost
viral
infect
although
classic
method
viral
discoveri
dismiss
investig
cumbersom
expens
quaint
continu
use
sever
reason
first
growth
agent
cultur
provid
excel
sourc
enrich
templat
molecular
character
addit
inoculum
anim
model
studi
cellbas
assay
serolog
titer
stock
neutral
test
greatli
aid
pursuit
proof
diseas
causat
stock
also
need
vitro
assess
vaccin
test
drug
candid
final
visual
agent
electron
microscopi
intellectu
satisfi
coup
de
grace
even
jade
microb
hunter
challeng
find
cell
line
allow
entri
replic
former
requir
express
appropri
receptor
instanc
coreceptor
latter
requir
host
factor
support
viru
transcript
replic
assembl
egress
anoth
impedi
induct
innat
immun
respons
imped
transcript
replic
andor
protein
synthesi
challeng
innat
immun
straightforward
address
respons
depress
use
antibodi
molecul
target
altern
pathway
current
solut
receptor
factor
challeng
test
multipl
cell
line
continu
primari
wide
rang
host
speci
unfortun
instanc
effort
fail
system
may
prove
use
viru
amplif
anim
inocul
advent
rapid
inexpens
unbias
high
throughput
sequenc
immunohistochemistri
frequent
first
step
toward
identifi
candid
molecular
assay
exampl
decis
pursu
flaviviru
consensu
pcr
brain
extract
victim
enceph
outbreak
new
york
guid
immunoassay
perform
sherif
zaki
center
diseas
control
atlanta
recent
imag
use
primarili
examin
strength
associ
infecti
agent
diseas
test
presenc
site
patholog
although
rapid
protocol
electron
microscopi
exist
allow
visual
virus
hour
requir
substanti
oper
expertis
high
agent
concentr
immunohistochem
assay
pursu
use
serum
either
affect
individu
one
similar
diseas
antibodi
gener
anim
model
inocul
viru
candid
immun
viral
protein
serum
alreadi
avail
approach
implement
rapidli
howev
truli
novel
agent
delay
requir
creat
immunolog
reagent
typic
measur
week
month
altern
pursu
situ
hybrid
littl
day
genet
sequenc
pathogen
candid
use
design
probe
examin
distribut
candid
tissu
clinic
syndrom
rare
pathognomon
infect
specif
agent
thu
although
singleplex
assay
common
clinic
microbiolog
multiplex
assay
use
differenti
amongst
like
candid
pathogen
also
exclud
effort
focus
discoveri
multiplex
pcr
assay
current
applic
detect
product
use
fluoresc
mass
spectroscopi
capillari
electrophoresi
highli
multiplex
address
mani
candid
agent
sensit
requir
analysi
clinic
materi
even
higher
level
multiplex
obtain
dna
microarray
compris
million
individu
probe
howev
sensit
may
insuffici
clinic
applic
drawback
may
ultim
overcom
use
nanofluid
electron
nanocircuitri
advent
rapid
inexpens
platform
dna
sequenc
revolution
microbiolog
provid
cultureindepend
method
pursu
viru
discoveri
character
surveil
outbreak
investig
past
year
per
base
cost
sequenc
decreas
per
megabas
use
capillari
electrophoresi
per
megabas
use
illumina
platform
accordingli
volum
sequenc
data
grown
exponenti
individu
experi
intern
data
repositori
challeng
shift
sequenc
acquisit
analysi
key
determin
complex
bioinformat
analysi
read
length
rang
bp
illumina
hiseq
miseq
instrument
bp
roch
gs
flx
titanium
pyrosequenc
shorter
read
length
greater
number
calcul
need
assembl
continu
string
genom
sequenc
addit
challeng
instrument
eg
gs
flx
ion
torrent
person
genom
machin
pgm
uncertainti
base
identif
caus
nucleotid
homopolym
although
singl
molecul
sequenc
develop
promis
provid
fidel
long
string
sequenc
data
current
strategi
mani
investig
use
gs
flx
pgm
platform
gener
scaffold
assembl
map
sequenc
data
illumina
instrument
irrespect
platform
process
follow
sequenc
acquisit
similar
pathogen
discoveri
contigu
sequenc
assembl
host
sequenc
subtract
residu
sequenc
examin
similar
known
microbi
sequenc
nucleotid
amino
acid
level
similar
found
one
examin
nucleotid
composit
andor
order
pattern
consist
viral
genera
host
speci
approach
also
help
decid
sequenc
merit
analysi
import
advantag
particularli
examin
fecal
specimen
sequenc
may
repres
virus
infect
host
plant
anim
consum
host
although
investig
individu
case
outbreak
diseas
still
typic
focu
first
test
presenc
specif
agent
use
singleplex
syndromespecif
multiplex
assay
cost
sequenc
continu
decreas
instrument
becom
portabl
method
sampl
prepar
sequenc
analysi
becom
user
friendli
anticip
sequenc
move
forefront
clinic
diagnosi
well
discoveri
although
wide
rang
genet
method
establish
multiplex
detect
virus
oligonucleotid
microarray
multiplex
pcr
sequenc
serolog
larg
confin
singleplex
method
employ
decad
includ
immunofluoresc
enzym
link
immunosorb
elisa
western
blot
later
flow
neutral
assay
thu
notabl
except
luminex
system
wherein
individu
bead
popul
decor
panel
differ
antigen
simultan
queri
investig
must
commit
test
specif
pathogen
hypothes
use
individu
test
rather
pursu
syndrom
surveil
wide
rang
agent
addit
challeng
develop
immunoassay
typic
time
consum
labor
intens
process
requir
prepar
antigen
product
character
antisera
valid
imposs
estim
rate
morbid
mortal
associ
infect
unless
one
determin
presenc
agent
individu
diseas
also
number
individu
infect
mild
diseas
despit
drawback
serolog
use
molecular
method
unsuccess
exampl
direct
mean
genet
detect
use
viral
nucleic
acid
present
access
sampl
eg
cerebrospin
fluid
case
enceph
diseas
may
trigger
agent
longer
present
eg
chronic
degen
diseas
risk
exposur
new
infecti
agent
modul
individu
previou
exposur
similar
agent
vaccin
exposur
may
confer
complet
partial
protect
result
increas
risk
sever
diseas
due
antibodymedi
enhanc
dengu
thu
knowledg
individu
immunolog
histori
may
influenc
decis
concern
hisher
treatment
vaccin
deploy
first
respond
health
care
worker
area
increas
probabl
encount
specif
pathogen
urgent
need
therefor
develop
serolog
platform
rapidli
deploy
new
agent
discov
simultan
detect
evid
exposur
one
agent
one
platform
luciferas
immunoprecipit
system
lip
quantit
highthroughput
liquid
phase
format
assay
wherein
viral
protein
antigen
fuse
enzym
report
renilla
luciferas
rel
express
mammalian
cell
harvest
incub
serum
staphylococc
protein
ag
magnet
bead
follow
precipit
luciferas
activ
determin
index
antibodi
concentr
establish
lip
assay
new
viru
develop
within
sever
day
acquisit
genom
sequenc
data
anoth
promis
platform
build
microarray
technolog
current
use
detect
nucleic
acid
pathogen
earli
version
base
spot
peptid
supplant
mm
mm
array
onto
peptid
synthes
situ
densiti
exceed
million
featur
densiti
alreadi
allow
design
tile
proteom
hundr
virus
print
densiti
increas
effici
scale
drive
cost
envis
high
throughput
multiplex
serolog
becom
feasibl
clinic
well
research
laboratori
recent
advanc
portabl
access
internet
afford
new
opportun
viral
surveil
discoveri
individu
rapidli
inexpens
share
report
outbreak
diseas
well
primer
sequenc
protocol
insight
request
assist
first
program
build
presenc
promedmail
programm
monitor
emerg
infecti
diseas
creat
provid
free
interact
intern
forum
report
discuss
outbreak
diseas
remain
activ
present
day
serv
subscrib
differ
countri
two
popular
program
gphin
global
public
health
intellig
network
healthmap
gphin
subscript
news
servic
review
media
report
web
entri
inform
concern
outbreak
healthmap
hybrid
passiv
activ
surveil
strategi
use
promedmail
gphin
respect
provid
userfriendli
map
diseas
emerg
inform
hyperlink
although
none
program
yet
integr
full
rang
data
sourc
potenti
contribut
global
awar
eg
medic
veterinari
servic
use
purchas
prescript
drug
overthecount
remedi
dramat
enhanc
commun
amongst
scientist
clinician
public
health
practition
laid
foundat
global
warn
system
enabl
focus
invest
surveil
discoveri
straightforward
exampl
pathogen
discoveri
investig
encount
outbreak
appear
transmiss
diseas
mani
individu
present
similar
sign
symptom
pattern
consist
either
direct
humantohuman
transmiss
exposur
common
sourc
whether
aerosol
enter
arbovir
high
concentr
agent
site
patholog
acut
present
diseas
howev
limit
microb
hunt
ideal
scenario
would
elimin
opportun
action
insight
chronic
sporad
disord
earli
zoonot
transmiss
event
host
factor
includ
age
nutrit
genet
context
coinfect
previou
exposur
relat
agent
profound
impact
suscept
infect
express
diseas
virus
caus
damag
site
infect
direct
result
replic
indirect
effect
innat
adapt
immun
respons
microbi
gene
product
may
also
induc
neoplasia
cell
cycl
interfer
gold
standard
proof
causat
criteria
establish
loeffler
koch
known
koch
postul
requir
agent
present
everi
case
diseas
specif
diseas
suffici
reproduc
diseas
cultur
inocul
host
other
includ
river
frederick
relman
current
author
propos
altern
criteria
allow
instanc
agent
propag
cultur
suitabl
anim
model
test
transmiss
diseas
well
infect
detail
strategi
pursu
causat
describ
recent
review
reli
upon
demonstr
strength
associ
assess
adapt
immun
candid
agent
quantit
viral
burden
demonstr
footprint
agent
site
patholog
biolog
plausibl
analog
diseas
associ
similar
agent
host
prevent
mitig
diseas
use
candidatespecif
drug
vaccin
figur
introduct
new
tool
surveil
diagnosi
discoveri
time
given
increas
global
travel
trade
factor
enhanc
emerg
reemerg
pathogen
virus
tool
applic
beyond
control
acut
diseas
anticip
lead
insight
pathogenesi
wide
rang
idiopath
condit
typic
ascrib
infect
neurodevelopment
autoimmun
neoplast
disord
concomit
advanc
method
vaccin
drug
develop
suggest
potenti
dramat
improv
health
welfar
enabl
enhanc
viral
intellig
stage
strategi
pathogen
discoveri
proof
causat
